Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Thermo Fisher Scientific Inc. (TMO) had Revenue of $12.21B for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$12.21B
Net Income	$1.96B
Cost of Goods Sold	$7.20B
Gross Profit	$5.01B
Operating Expenses	$9.96B
Operating Income	$2.25B
Non-Operating Income/Expense	$-100.00M
Pre-Tax Income	$2.15B
Normalized Pre-Tax Income	$2.15B
Income after Taxes	$2.00B
Income from Continuous Operations	$1.97B
Consolidated Net Income/Loss	$1.97B
Normalized Income after Taxes	$2.00B
EBIT	$2.25B
EBITDA	$2.98B
Weighted-Average Shares Outstanding (Basic)	377.00M
Weighted-Average Shares Outstanding (Diluted)	378.00M
Earnings per Share (EPS) (Basic)	$5.22
Earnings per Share (EPS) (Diluted)	$5.21
Balance Sheet Financials
Current Assets	$28.71B
Property, Plant, and Equipment	$10.56B
Long-Term Assets	$81.64B
Total Assets	$110.34B
Current Liabilities	$15.19B
Long-Term Debt	$35.85B
Long-Term Liabilities	$41.74B
Total Liabilities	$56.93B
Common Equity	$53.41B
Tangible Shareholders Equity	$-11.79B
Shareholders Equity	$53.41B
Common Shares Outstanding	376.22M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$7.82B
Cash Flow from Investing Activities	$-4.05B
Cash Flow from Financial Activities	$1.80B
Beginning Cash	$4.04B
End Cash	$9.88B
Increase/Decrease in Cash	$5.84B
Stock-Based Compensation	$310.00M
Common Stock Dividends Paid	$-636.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.89
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.40
Debt to Equity Ratio	0.74
Gross Margin	41.02%
Operating Margin	18.46%
EBIT Margin	18.46%
EBITDA Margin	--
Pre-Tax Profit Margin	17.63%
Profit Margin	16.08%
Free Cash Flow	$6.34B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.11
Inventory Turnover	1.33
Receiveable Turnover	1.37
Days Sales in Receivables	65.58
Return on Equity	3.69%
Return on Tangible Equity	-16.71%
Return on Assets	1.78%
Return on Investments	2.21%
Book Value Per Share	$141.98
Free Cash Flow per Share	$16.76
Operating Cash Flow per Share	$20.68

Data from Zacks Investment Research, Inc.